Commercial Physical & Biological Research Industry - SEC Form 4 Insider Trading Screener
Services Sector - Engineering, Accounting, Research, Management Services - Commercial Physical & Biological Research
100 results - 
- 
- 
- 
- 
- 
- - - - - | TC | cnt | 1d | 1w | 1m | 6m |
X |
Filing Date |
Trade Date |
Ticker |
Company | Insider Name | Insider Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2020-09-16 | PGEN | Precigen, Inc. | Sterling Rick L. | CFO | S - Sale+OE | $5.22 | -7,660 | 305,313 | -2% | -$39,985 | |||||
| D | 2020-09-16 | PGEN | Precigen, Inc. | Perez Jeffrey Thomas | SVP, IP Affairs | S - Sale+OE | $5.22 | -7,660 | 243,229 | -3% | -$39,985 | |||||
| D | 2020-09-16 | PGEN | Precigen, Inc. | Lehr Donald P. | GC | S - Sale+OE | $5.22 | -8,474 | 248,084 | -3% | -$44,234 | |||||
| D | 2020-09-15 | IQV | Iqvia Holdings Inc. | Bousbib Ari | See Remarks | S - Sale+OE | $164.36 | -46,080 | 1,195,337 | -4% | -$7,573,709 | |||||
| D | 2020-09-16 | EXEL | Exelixis, Inc. | Hessekiel Jeffrey | EVP, GC | S - Sale+OE | $26.11 | -20,000 | 344,025 | -5% | -$522,200 | |||||
| D | 2020-09-15 | EXEL | Exelixis, Inc. | Senner Christopher J. | EVP, CFO | S - Sale+OE | $25.00 | -20,000 | 130,605 | -13% | -$500,000 | |||||
2020-09-14 | CRL | Charles River Laboratories International, Inc. | Massaro George | Dir | S - Sale | $219.91 | -1,943 | 9,441 | -17% | -$427,284 | ||||||
| D | 2020-09-10 | INCY | Incyte Corp | Pasquale Maria E | EVP, GC | S - Sale+OE | $90.83 | -2,193 | 28,331 | -7% | -$199,190 | |||||
| M | 2020-09-01 | BUDZ | Weed, Inc. | Breen Nicole M | Secretary, Treasurer, 10% | S - Sale | $0.21 | -27,020 | 22,714,489 | 0% | -$5,552 | |||||
| D | 2020-09-08 | INCY | Incyte Corp | Dhanak Dashyant | EVP, Chief Scientific Officer | S - Sale+OE | $88.94 | -961 | 28,010 | -3% | -$85,471 | |||||
| M | 2020-09-04 | TENX | Tenax Therapeutics, Inc. | Armistice Capital, LLC | Dir, 10% | P - Purchase | $1.42 | +32,000 | 4,039,990 | +1% | +$45,547 | |||||
2020-09-02 | NRC | National Research Corp | Jackson Steven D. | Pres | S - Sale | $57.85 | -5,000 | 79,696 | -6% | -$289,250 | ||||||
| M | 2020-09-01 | TENX | Tenax Therapeutics, Inc. | Armistice Capital, LLC | Dir, 10% | P - Purchase | $1.43 | +86,000 | 3,975,990 | +2% | +$123,240 | |||||
2020-09-01 | EXAS | Exact Sciences Corp | Conroy Kevin T | Pres, CEO | S - Sale | $75.03 | -19,927 | 1,039,833 | -2% | -$1,495,123 | ||||||
| DM | 2020-08-31 | MEDP | Medpace Holdings, Inc. | Geiger Jesse J | CFO, COO, Lab Operations | S - Sale+OE | $130.00 | -6,810 | 6,382 | -52% | -$885,300 | |||||
| M | 2020-08-24 | BUDZ | Weed, Inc. | Breen Nicole M | Secretary, Treasurer, 10% | S - Sale | $0.23 | -36,800 | 22,741,509 | 0% | -$8,477 | |||||
| M | 2020-08-27 | TENX | Tenax Therapeutics, Inc. | Armistice Capital, LLC | Dir, 10% | P - Purchase | $1.47 | +32,000 | 3,803,990 | +1% | +$47,000 | |||||
| D | 2020-08-27 | INCY | Incyte Corp | Dixon Wendy L | Dir | S - Sale+OE | $94.51 | -20,000 | 14,243 | -58% | -$1,890,200 | |||||
| M | 2020-08-26 | MEDP | Medpace Holdings, Inc. | Medpace Investors, LLC | 10% | S - Sale | $123.33 | -15,923 | 6,790,766 | 0% | -$1,963,734 | |||||
| M | 2020-08-26 | MEDP | Medpace Holdings, Inc. | Troendle August J. | Pres, CEO, 10% | S - Sale | $123.33 | -15,923 | 7,407,409 | 0% | -$1,963,734 | |||||
| M | 2020-08-24 | TENX | Tenax Therapeutics, Inc. | Armistice Capital, LLC | 10% | P - Purchase | $1.51 | +34,903 | 3,739,990 | +1% | +$52,700 | |||||
| M | 2020-08-24 | MEDP | Medpace Holdings, Inc. | Troendle August J. | Pres, CEO, 10% | S - Sale | $123.31 | -30,500 | 7,423,332 | 0% | -$3,760,972 | |||||
| M | 2020-08-24 | MEDP | Medpace Holdings, Inc. | Medpace Investors, LLC | 10% | S - Sale | $123.31 | -30,500 | 6,806,689 | 0% | -$3,760,972 | |||||
| M | 2020-08-20 | MEDP | Medpace Holdings, Inc. | Troendle August J. | Pres, CEO, 10% | S - Sale | $125.01 | -43,117 | 7,453,832 | -1% | -$5,389,928 | |||||
| M | 2020-08-20 | MEDP | Medpace Holdings, Inc. | Medpace Investors, LLC | 10% | S - Sale | $125.01 | -43,117 | 6,837,189 | -1% | -$5,389,928 | |||||
| M | 2020-08-17 | BUDZ | Weed, Inc. | Breen Nicole M | Secretary, Treasurer, 10% | S - Sale | $0.24 | -26,000 | 22,778,309 | 0% | -$6,328 | |||||
| M | 2020-08-19 | TENX | Tenax Therapeutics, Inc. | Armistice Capital, LLC | Dir, 10% | P - Purchase | $1.48 | +311,481 | 3,670,184 | +9% | +$460,443 | |||||
| D | 2020-08-19 | EXAS | Exact Sciences Corp | Hoof Torsten | GM, International | S - Sale+OE | $84.90 | -7,964 | 2,017 | -80% | -$676,144 | |||||
2020-08-20 | CRL | Charles River Laboratories International, Inc. | Girshick Birgit | Corporate EVP | S - Sale | $213.51 | -933 | 22,852 | -4% | -$199,205 | ||||||
| M | 2020-08-18 | MEDP | Medpace Holdings, Inc. | Medpace Investors, LLC | 10% | S - Sale | $127.47 | -38,203 | 6,880,306 | -1% | -$4,869,711 | |||||
| M | 2020-08-18 | MEDP | Medpace Holdings, Inc. | Troendle August J. | Pres, CEO, 10% | S - Sale | $127.47 | -38,203 | 7,496,949 | -1% | -$4,869,711 | |||||
2020-08-19 | BASI | Bioanalytical Systems Inc | Sagartz John E | Chief Strategy Officer | P - Purchase | $4.75 | +3,733 | 634,232 | +1% | +$17,732 | ||||||
2020-08-19 | BASI | Bioanalytical Systems Inc | Neff R Matthew | Dir | P - Purchase | $4.75 | +5,000 | 60,350 | +9% | +$23,750 | ||||||
| D | 2020-08-17 | MEDP | Medpace Holdings, Inc. | Geiger Jesse J | CFO, COO, Lab Operations | S - Sale+OE | $128.00 | -3,500 | 6,382 | -35% | -$448,000 | |||||
2020-08-18 | CRL | Charles River Laboratories International, Inc. | Chubb Stephen D | Dir | S - Sale | $217.65 | -1,000 | 37,657 | -3% | -$217,651 | ||||||
| D | 2020-08-14 | IQV | Iqvia Holdings Inc. | Bousbib Ari | See Remarks | S - Sale+OE | $161.66 | -69,120 | 1,195,337 | -5% | -$11,173,939 | |||||
| M | 2020-08-14 | MEDP | Medpace Holdings, Inc. | Troendle August J. | Pres, CEO, 10% | S - Sale | $127.62 | -33,342 | 7,535,152 | 0% | -$4,255,066 | |||||
| M | 2020-08-14 | MEDP | Medpace Holdings, Inc. | Medpace Investors, LLC | 10% | S - Sale | $127.62 | -33,342 | 6,918,509 | 0% | -$4,255,066 | |||||
| M | 2020-08-10 | BUDZ | Weed, Inc. | Breen Nicole M | Secretary, Treasurer, 10% | S - Sale | $0.25 | -36,000 | 22,804,309 | 0% | -$9,091 | |||||
2020-08-13 | PRAH | Pra Health Sciences, Inc. | Shannon Colin | Pres, CEO | S - Sale | $102.88 | -6,073 | 56,927 | -10% | -$624,790 | ||||||
2020-08-13 | PRAH | Pra Health Sciences, Inc. | Gaenzle Christopher L | EVP, CAO, GC | S - Sale | $102.88 | -1,364 | 37,636 | -3% | -$140,328 | ||||||
2020-08-13 | PRAH | Pra Health Sciences, Inc. | Bonello Michael J. | EVP, CFO | S - Sale | $102.88 | -2,052 | 21,276 | -9% | -$211,110 | ||||||
| M | 2020-08-12 | MEDP | Medpace Holdings, Inc. | Troendle August J. | Pres, CEO, 10% | S - Sale | $127.50 | -38,587 | 7,568,494 | -1% | -$4,919,655 | |||||
| M | 2020-08-12 | MEDP | Medpace Holdings, Inc. | Medpace Investors, LLC | 10% | S - Sale | $127.50 | -38,587 | 6,951,851 | -1% | -$4,919,655 | |||||
| M | 2020-08-11 | PGEN | Precigen, Inc. | Kirk Randal J | Exec COB, 10% | P - Purchase | $4.42 | +1,209,384 | 27,667,333 | +5% | +$5,346,020 | |||||
| M | 2020-08-10 | MEDP | Medpace Holdings, Inc. | Troendle August J. | Pres, CEO, 10% | S - Sale | $122.80 | -86,790 | 7,607,081 | -1% | -$10,657,640 | |||||
| M | 2020-08-10 | MEDP | Medpace Holdings, Inc. | Medpace Investors, LLC | 10% | S - Sale | $122.80 | -86,790 | 6,990,438 | -1% | -$10,657,640 | |||||
| D | 2020-08-10 | MEDP | Medpace Holdings, Inc. | Ewald Stephen P | GC, Corp. Secy. | S - Sale+OE | $121.57 | -7,400 | 3,336 | -69% | -$899,618 | |||||
| M | 2020-08-05 | BUDZ | Weed, Inc. | Breen Nicole M | Secretary, Treasurer, 10% | S - Sale | $0.26 | -24,000 | 22,840,309 | 0% | -$6,292 | |||||
| D | 2020-08-07 | IQV | Iqvia Holdings Inc. | Staub W Richard | See Remarks | S - Sale+OE | $160.32 | -20,367 | 12,470 | -62% | -$3,265,332 | |||||
2020-08-07 | CRL | Charles River Laboratories International, Inc. | Kochevar Deborah Turner | Dir | S - Sale | $216.24 | -2,319 | 6,728 | -26% | -$501,467 | ||||||
2020-08-07 | CRL | Charles River Laboratories International, Inc. | Foster James C | COB, Pres, CEO | S - Sale | $217.49 | -24,000 | 281,917 | -8% | -$5,219,771 | ||||||
| D | 2020-08-06 | INCY | Incyte Corp | Dhanak Dashyant | EVP, Chief Scientific Officer | S - Sale+OE | $97.80 | -961 | 28,010 | -3% | -$93,986 | |||||
| D | 2020-08-07 | CRL | Charles River Laboratories International, Inc. | Smith David Ross | Corporate EVP, CFO | S - Sale+OE | $216.54 | -3,304 | 20,767 | -14% | -$715,444 | |||||
2020-08-06 | MEDP | Medpace Holdings, Inc. | Burwig Susan E | EVP, Operations | S - Sale | $126.00 | -7,000 | 39,179 | -15% | -$882,000 | ||||||
| M | 2020-08-06 | MEDP | Medpace Holdings, Inc. | Troendle August J. | Pres, CEO, 10% | S - Sale | $123.11 | -34,975 | 7,693,871 | 0% | -$4,305,920 | |||||
| M | 2020-08-06 | MEDP | Medpace Holdings, Inc. | Medpace Investors, LLC | 10% | S - Sale | $123.11 | -34,975 | 7,077,228 | 0% | -$4,305,920 | |||||
| D | 2020-08-07 | CRL | Charles River Laboratories International, Inc. | Knell Michael Gunnar | CSVP, Chief Accounting Officer | S - Sale+OE | $216.60 | -3,456 | 2,399 | -59% | -$748,555 | |||||
| M | 2020-08-04 | MEDP | Medpace Holdings, Inc. | Troendle August J. | Pres, CEO, 10% | S - Sale | $124.57 | -58,667 | 7,728,846 | -1% | -$7,307,974 | |||||
| M | 2020-08-04 | MEDP | Medpace Holdings, Inc. | Medpace Investors, LLC | 10% | S - Sale | $124.57 | -58,667 | 7,112,203 | -1% | -$7,307,974 | |||||
2020-08-04 | IQV | Iqvia Holdings Inc. | Bruehlman Ronald E | See Remarks | P - Purchase | $159.94 | +10,000 | 26,751 | +60% | +$1,599,400 | ||||||
| D | 2020-07-31 | EXAS | Exact Sciences Corp | Carey Thomas D. | Dir | S - Sale+OE | $94.00 | -30,620 | 21,872 | -58% | -$2,878,280 | |||||
2020-08-03 | EXAS | Exact Sciences Corp | Conroy Kevin T | Pres, CEO | S - Sale | $93.80 | -25,198 | 1,059,760 | -2% | -$2,363,560 | ||||||
2020-08-03 | SYNH | Syneos Health, Inc. | Macdonald Alistair | CEO | S - Sale | $65.07 | -10,289 | 246,687 | -4% | -$669,464 | ||||||
| D | 2020-07-31 | EXAS | Exact Sciences Corp | Elliott Jeffrey Thomas | CFO | S - Sale+OE | $93.83 | -37,500 | 39,508 | -49% | -$3,518,771 | |||||
| D | 2020-07-31 | EXAS | Exact Sciences Corp | Levangie Daniel J | Dir | S - Sale+OE | $94.00 | -9,865 | 15,016 | -40% | -$927,310 | |||||
| D | 2020-07-31 | EXAS | Exact Sciences Corp | Zanotti Katherine S | Dir | S - Sale+OE | $94.00 | -21,029 | 78,907 | -21% | -$1,976,726 | |||||
2020-07-31 | EXAS | Exact Sciences Corp | Doyle James Edward | Dir | S - Sale | $94.00 | -2,539 | 32,459 | -7% | -$238,666 | ||||||
| M | 2020-07-31 | MEDP | Medpace Holdings, Inc. | Medpace Investors, LLC | 10% | S - Sale | $120.59 | -66,627 | 7,170,870 | -1% | -$8,034,262 | |||||
| M | 2020-07-31 | MEDP | Medpace Holdings, Inc. | Troendle August J. | Pres, CEO, 10% | S - Sale | $120.59 | -66,627 | 7,787,513 | -1% | -$8,034,262 | |||||
2020-07-30 | MEDP | Medpace Holdings, Inc. | Burwig Susan E | EVP, Operations | S - Sale | $121.14 | -6,000 | 46,179 | -11% | -$726,840 | ||||||
| M | 2020-07-29 | MEDP | Medpace Holdings, Inc. | Medpace Investors, LLC | 10% | S - Sale | $122.46 | -90,061 | 7,237,497 | -1% | -$11,029,207 | |||||
| M | 2020-07-29 | MEDP | Medpace Holdings, Inc. | Troendle August J. | Pres, CEO, 10% | S - Sale | $122.46 | -90,061 | 7,854,140 | -1% | -$11,029,207 | |||||
| D | 2020-07-29 | EXAS | Exact Sciences Corp | Elliott Jeffrey Thomas | CFO | S - Sale+OE | $95.58 | -8,746 | 70,370 | -11% | -$835,943 | |||||
2020-07-28 | EXAS | Exact Sciences Corp | Zanotti Katherine S | Dir | S - Sale | $96.13 | -1,164 | 78,907 | -1% | -$111,895 | ||||||
2020-07-28 | IQV | Iqvia Holdings Inc. | Tpg Group Holdings (Sbs) Advisors, Inc. | Former Director | S - Sale | $159.12 | -2,919,051 | 0 | -100% | -$464,479,395 | ||||||
| M | 2020-07-27 | MEDP | Medpace Holdings, Inc. | Troendle August J. | Pres, CEO, 10% | S - Sale | $125.23 | -243,518 | 7,944,201 | -3% | -$30,495,276 | |||||
| M | 2020-07-27 | MEDP | Medpace Holdings, Inc. | Medpace Investors, LLC | 10% | S - Sale | $125.23 | -243,518 | 7,327,558 | -3% | -$30,495,276 | |||||
| D | 2020-07-23 | NRC | National Research Corp | Nunnelly John N | Dir | S - Sale+OE | $60.10 | -5,926 | 26,894 | -18% | -$356,164 | |||||
2020-07-23 | NRC | National Research Corp | Martin Joann M | Dir | S - Sale | $60.00 | -19,853 | 254,539 | -7% | -$1,191,180 | ||||||
| M | 2020-07-23 | MEDP | Medpace Holdings, Inc. | Medpace Investors, LLC | 10% | S - Sale | $108.87 | -66,123 | 7,571,076 | -1% | -$7,198,569 | |||||
| M | 2020-07-23 | MEDP | Medpace Holdings, Inc. | Troendle August J. | Pres, CEO, 10% | S - Sale | $108.87 | -66,123 | 8,187,719 | -1% | -$7,198,569 | |||||
| D | 2020-07-22 | IQV | Iqvia Holdings Inc. | Bousbib Ari | See Remarks | S - Sale+OE | $160.00 | -46,080 | 1,195,337 | -4% | -$7,372,800 | |||||
| M | 2020-07-21 | MEDP | Medpace Holdings, Inc. | Troendle August J. | Pres, CEO, 10% | S - Sale | $108.58 | -63,968 | 8,253,842 | -1% | -$6,945,671 | |||||
| M | 2020-07-21 | MEDP | Medpace Holdings, Inc. | Medpace Investors, LLC | 10% | S - Sale | $108.58 | -63,968 | 7,637,199 | -1% | -$6,945,671 | |||||
2020-07-20 | EXEL | Exelixis, Inc. | Haley Patrick J. | EVP, Commercial | S - Sale | $25.36 | -3,151 | 146,376 | -2% | -$79,909 | ||||||
2020-07-21 | PIRS | Pieris Pharmaceuticals, Inc. | Aquilo Capital Management, LLC | 10% | S - Sale | $2.95 | -1,900,000 | 3,675,530 | -34% | -$5,605,000 | ||||||
| D | 2020-07-20 | PGEN | Precigen, Inc. | Sabzevari Helen | Pres, CEO | S - Sale+OE | $4.58 | -12,220 | 402,145 | -3% | -$55,968 | |||||
2020-07-17 | NRC | National Research Corp | Martin Joann M | Dir | S - Sale | $60.00 | -110 | 274,392 | 0% | -$6,600 | ||||||
| M | 2020-07-17 | MEDP | Medpace Holdings, Inc. | Troendle August J. | Pres, CEO, 10% | S - Sale | $105.39 | -37,044 | 8,317,810 | 0% | -$3,904,134 | |||||
| M | 2020-07-17 | MEDP | Medpace Holdings, Inc. | Medpace Investors, LLC | 10% | S - Sale | $105.39 | -37,044 | 7,701,167 | 0% | -$3,904,134 | |||||
| D | 2020-07-15 | SYNH | Syneos Health, Inc. | Macdonald Alistair | CEO | S - Sale+OE | $60.14 | -37,868 | 261,154 | -13% | -$2,277,495 | |||||
2020-07-16 | INCY | Incyte Corp | Stein Steven H | EVP, Chief Medical Officer | S - Sale | $103.83 | -766 | 95,468 | -1% | -$79,534 | ||||||
| M | 2020-07-15 | MEDP | Medpace Holdings, Inc. | Troendle August J. | Pres, CEO, 10% | S - Sale | $104.48 | -43,973 | 8,354,854 | -1% | -$4,594,440 | |||||
| M | 2020-07-15 | MEDP | Medpace Holdings, Inc. | Medpace Investors, LLC | 10% | S - Sale | $104.48 | -43,973 | 7,738,211 | -1% | -$4,594,440 | |||||
2020-07-15 | NRC | National Research Corp | Martin Joann M | Dir | S - Sale | $60.00 | -14 | 274,502 | 0% | -$840 | ||||||
| DM | 2020-07-13 | SYNH | Syneos Health, Inc. | Macdonald Alistair | CEO | S - Sale+OE | $58.48 | -8,828 | 261,154 | -3% | -$516,300 | |||||
| M | 2020-06-15 | BUDZ | Weed, Inc. | Kwestel Elliot | Director of WEED Israel Ltd. | S - Sale | $0.31 | -17,889 | 82,111 | -18% | -$5,559 | |||||
| M | 2020-07-09 | MEDP | Medpace Holdings, Inc. | Medpace Investors, LLC | 10% | S - Sale | $100.40 | -8,582 | 7,782,184 | 0% | -$861,632 | |||||
| M | 2020-07-09 | MEDP | Medpace Holdings, Inc. | Troendle August J. | Pres, CEO, 10% | S - Sale | $100.40 | -8,582 | 8,398,827 | 0% | -$861,632 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |